Claudia M. Espitia

1.6k total citations
39 papers, 1.1k citations indexed

About

Claudia M. Espitia is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Claudia M. Espitia has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Claudia M. Espitia's work include Virus-based gene therapy research (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Protein Degradation and Inhibitors (7 papers). Claudia M. Espitia is often cited by papers focused on Virus-based gene therapy research (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Protein Degradation and Inhibitors (7 papers). Claudia M. Espitia collaborates with scholars based in United States, Japan and Colombia. Claudia M. Espitia's co-authors include Jennifer S. Carew, Steffan T. Nawrocki, Kevin R. Kelly, Francis J. Giles, Devalingam Mahalingam, Alain C. Mita, Monica Mita, Weiguo Zhao, Juan Esquivel and Steffan T. Nawrocki and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Claudia M. Espitia

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia M. Espitia United States 17 646 404 270 159 111 39 1.1k
Philippe Nirdé France 15 387 0.6× 262 0.6× 129 0.5× 188 1.2× 75 0.7× 24 836
Makoto Yoshimitsu Japan 23 567 0.9× 240 0.6× 429 1.6× 124 0.8× 122 1.1× 102 1.7k
Alejandra Raimondi United States 12 1.5k 2.3× 196 0.5× 208 0.8× 93 0.6× 125 1.1× 27 1.9k
Thomas Falguières France 21 703 1.1× 167 0.4× 271 1.0× 113 0.7× 43 0.4× 37 1.4k
Karin Sedelies Australia 16 791 1.2× 212 0.5× 266 1.0× 70 0.4× 87 0.8× 18 1.2k
Mhairi Skinner Canada 10 551 0.9× 129 0.3× 160 0.6× 58 0.4× 73 0.7× 28 888
Molly L. Bristol United States 18 394 0.6× 560 1.4× 288 1.1× 107 0.7× 159 1.4× 32 908
Ohad Shifman Israel 12 1.4k 2.1× 408 1.0× 829 3.1× 101 0.6× 218 2.0× 30 1.7k
Joachim Lupberger France 19 484 0.7× 626 1.5× 136 0.5× 78 0.5× 104 0.9× 37 1.4k
Jane M. Turbov United States 14 515 0.8× 99 0.2× 155 0.6× 104 0.7× 143 1.3× 19 1.0k

Countries citing papers authored by Claudia M. Espitia

Since Specialization
Citations

This map shows the geographic impact of Claudia M. Espitia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia M. Espitia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia M. Espitia more than expected).

Fields of papers citing papers by Claudia M. Espitia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia M. Espitia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia M. Espitia. The network helps show where Claudia M. Espitia may publish in the future.

Co-authorship network of co-authors of Claudia M. Espitia

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia M. Espitia. A scholar is included among the top collaborators of Claudia M. Espitia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia M. Espitia. Claudia M. Espitia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Espitia, Claudia M., Juan Chipollini, Benjamin R. Lee, et al.. (2023). Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity. Cancer Research Communications. 3(2). 245–257. 3 indexed citations
4.
Espitia, Claudia M., et al.. (2023). Invariant measures for stochastic parabolic–hyperbolic equations in the space of almost periodic functions: Lipschitz flux case. Journal of Hyperbolic Differential Equations. 20(3). 745–792.
5.
6.
Kathawala, Rishil J., Claudia M. Espitia, Pranav Gupta, et al.. (2020). ABCG2 Overexpression Contributes to Pevonedistat Resistance. Cancers. 12(2). 429–429. 13 indexed citations
7.
Espitia, Claudia M., et al.. (2019). Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies. Cancer Communications. 39(1). 72–72. 19 indexed citations
8.
Carew, Jennifer S., Claudia M. Espitia, Weiguo Zhao, et al.. (2019). Rational cotargeting of HDAC6 and BET proteins yields synergistic antimyeloma activity. Blood Advances. 3(8). 1318–1329. 22 indexed citations
9.
Carew, Jennifer S., Claudia M. Espitia, Yingchun Han, et al.. (2016). Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis. Clinical Cancer Research. 23(11). 2869–2879. 54 indexed citations
10.
Mahalingam, Devalingam, Monica Mita, John Sarantopoulos, et al.. (2014). Combined autophagy and HDAC inhibition. Autophagy. 10(8). 1403–1414. 241 indexed citations
11.
Nawrocki, Steffan T., Kevin R. Kelly, Peter G. Smith, et al.. (2013). Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer. Clinical Cancer Research. 19(13). 3577–3590. 89 indexed citations
12.
Carew, Jennifer S., Claudia M. Espitia, Weiguo Zhao, et al.. (2013). Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer. Cell Death and Disease. 4(7). e728–e728. 56 indexed citations
13.
Carew, Jennifer S., Juan Esquivel, Claudia M. Espitia, et al.. (2012). ELR510444 Inhibits Tumor Growth and Angiogenesis by Abrogating HIF Activity and Disrupting Microtubules in Renal Cell Carcinoma. PLoS ONE. 7(1). e31120–e31120. 17 indexed citations
14.
Osorio, E. Yaneth, Weiguo Zhao, Claudia M. Espitia, et al.. (2012). Progressive Visceral Leishmaniasis Is Driven by Dominant Parasite-induced STAT6 Activation and STAT6-dependent Host Arginase 1 Expression. PLoS Pathogens. 8(1). e1002417–e1002417. 48 indexed citations
15.
Mahalingam, Devalingam, Claudia M. Espitia, Ernest Medina, et al.. (2011). Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma. British Journal of Cancer. 105(10). 1563–1573. 21 indexed citations
16.
Griffin, Patrick R., Steffan T. Nawrocki, Takashi Satou, et al.. (2011). The Investigational Multi-Targeted Kinase Inhibitor TAK-901 Antagonizes Acute Myeloid Leukemia Pathogenesis: Results of Preclinical Studies. Blood. 118(21). 581–581.
17.
Espitia, Claudia M., Weiguo Zhao, Ómar A. Saldarriaga, et al.. (2010). Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis. BMC Immunology. 11(1). 31–31. 41 indexed citations
18.
Carew, Jennifer S., Claudia M. Espitia, Juan Esquivel, et al.. (2010). Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis. Journal of Biological Chemistry. 286(8). 6602–6613. 114 indexed citations
19.
Escobar, María Fernanda, et al.. (2005). Detección de Helicobacter pylori en tejido aórtico humano mediante la amplificación del gen del 16S rDNA. Revista Colombiana de Cardiología. 12(4). 157–162. 1 indexed citations
20.
Salas, Natalia, et al.. (2005). Detección de Chlamydia pneumoniae en tejido aórtico humano: amplificación del gen kdtA e hibridación in vitro.. Biomédica. 25(4). 511–511. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Nirdé Breakdown of academic impact, for papers by Makoto Yoshimitsu Breakdown of academic impact, for papers by Alejandra Raimondi Breakdown of academic impact, for papers by Thomas Falguières Breakdown of academic impact, for papers by Karin Sedelies Breakdown of academic impact, for papers by Mhairi Skinner Breakdown of academic impact, for papers by Molly L. Bristol Breakdown of academic impact, for papers by Ohad Shifman Breakdown of academic impact, for papers by Joachim Lupberger Breakdown of academic impact, for papers by Jane M. Turbov
Rankless by CCL
2026